Copyright Reports & Markets. All rights reserved.

Global Glucose Dependent Insulinotropic Receptor Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Glucose Dependent Insulinotropic Receptor Market Overview

      • 1.1 Product Overview and Scope of Glucose Dependent Insulinotropic Receptor
      • 1.2 Glucose Dependent Insulinotropic Receptor Segment by Type
        • 1.2.1 Global Glucose Dependent Insulinotropic Receptor Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 DA-1241
        • 1.2.3 GSK-2041706
        • 1.2.4 HD-0471042
        • 1.2.5 HD-0471953
        • 1.2.6 HOB-047
        • 1.2.7 MBX-2982
        • 1.2.8 Others
      • 1.3 Glucose Dependent Insulinotropic Receptor Segment by Application
        • 1.3.1 Glucose Dependent Insulinotropic Receptor Consumption Comparison by Application (2014-2025)
        • 1.3.2 Type 2 Diabetes
        • 1.3.3 Obesity
        • 1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
        • 1.3.5 Dyslipidemia
        • 1.3.6 Others
      • 1.3 Global Glucose Dependent Insulinotropic Receptor Market by Region
        • 1.3.1 Global Glucose Dependent Insulinotropic Receptor Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Glucose Dependent Insulinotropic Receptor Market Size
        • 1.4.1 Global Glucose Dependent Insulinotropic Receptor Revenue (2014-2025)
        • 1.4.2 Global Glucose Dependent Insulinotropic Receptor Production (2014-2025)

      2 Global Glucose Dependent Insulinotropic Receptor Market Competition by Manufacturers

      • 2.1 Global Glucose Dependent Insulinotropic Receptor Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Glucose Dependent Insulinotropic Receptor Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Glucose Dependent Insulinotropic Receptor Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Glucose Dependent Insulinotropic Receptor Production Sites, Area Served, Product Types
      • 2.5 Glucose Dependent Insulinotropic Receptor Market Competitive Situation and Trends
        • 2.5.1 Glucose Dependent Insulinotropic Receptor Market Concentration Rate
        • 2.5.2 Glucose Dependent Insulinotropic Receptor Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Glucose Dependent Insulinotropic Receptor Production Market Share by Regions

      • 3.1 Global Glucose Dependent Insulinotropic Receptor Production Market Share by Regions
      • 3.2 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Glucose Dependent Insulinotropic Receptor Production
        • 3.4.1 North America Glucose Dependent Insulinotropic Receptor Production Growth Rate (2014-2019)
        • 3.4.2 North America Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Glucose Dependent Insulinotropic Receptor Production
        • 3.5.1 Europe Glucose Dependent Insulinotropic Receptor Production Growth Rate (2014-2019)
        • 3.5.2 Europe Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Glucose Dependent Insulinotropic Receptor Production (2014-2019)
        • 3.6.1 China Glucose Dependent Insulinotropic Receptor Production Growth Rate (2014-2019)
        • 3.6.2 China Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Glucose Dependent Insulinotropic Receptor Production (2014-2019)
        • 3.7.1 Japan Glucose Dependent Insulinotropic Receptor Production Growth Rate (2014-2019)
        • 3.7.2 Japan Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Glucose Dependent Insulinotropic Receptor Consumption by Regions

      • 4.1 Global Glucose Dependent Insulinotropic Receptor Consumption by Regions
      • 4.2 North America Glucose Dependent Insulinotropic Receptor Consumption (2014-2019)
      • 4.3 Europe Glucose Dependent Insulinotropic Receptor Consumption (2014-2019)
      • 4.4 China Glucose Dependent Insulinotropic Receptor Consumption (2014-2019)
      • 4.5 Japan Glucose Dependent Insulinotropic Receptor Consumption (2014-2019)

      5 Global Glucose Dependent Insulinotropic Receptor Production, Revenue, Price Trend by Type

      • 5.1 Global Glucose Dependent Insulinotropic Receptor Production Market Share by Type (2014-2019)
      • 5.2 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2014-2019)
      • 5.3 Global Glucose Dependent Insulinotropic Receptor Price by Type (2014-2019)
      • 5.4 Global Glucose Dependent Insulinotropic Receptor Production Growth by Type (2014-2019)

      6 Global Glucose Dependent Insulinotropic Receptor Market Analysis by Applications

      • 6.1 Global Glucose Dependent Insulinotropic Receptor Consumption Market Share by Application (2014-2019)
      • 6.2 Global Glucose Dependent Insulinotropic Receptor Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Glucose Dependent Insulinotropic Receptor Business

      • 7.1 Amgen Inc
        • 7.1.1 Amgen Inc Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.1.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.1.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Arena Pharmaceuticals Inc
        • 7.2.1 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.2.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.2.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 CymaBay Therapeutics Inc
        • 7.3.1 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.3.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.3.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Dong-A Socio Holdings Co Ltd
        • 7.4.1 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.4.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.4.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 F. Hoffmann-La Roche Ltd
        • 7.5.1 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.5.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.5.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 GlaxoSmithKline Plc
        • 7.6.1 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.6.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.6.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Hyundai Pharmaceutical Co Ltd
        • 7.7.1 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.7.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.7.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Kowa Co Ltd
        • 7.8.1 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.8.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Merck & Co Inc
        • 7.9.1 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.9.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Novartis AG
        • 7.10.1 Novartis AG Glucose Dependent Insulinotropic Receptor Production Sites and Area Served
        • 7.10.2 Glucose Dependent Insulinotropic Receptor Product Introduction, Application and Specification
        • 7.10.3 Novartis AG Glucose Dependent Insulinotropic Receptor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Taisho Pharmaceutical Holdings Co Ltd
      • 7.12 Takeda Pharmaceutical Co Ltd
      • 7.13 Yuhan Corp

      8 Glucose Dependent Insulinotropic Receptor Manufacturing Cost Analysis

      • 8.1 Glucose Dependent Insulinotropic Receptor Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Glucose Dependent Insulinotropic Receptor
      • 8.4 Glucose Dependent Insulinotropic Receptor Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Glucose Dependent Insulinotropic Receptor Distributors List
      • 9.3 Glucose Dependent Insulinotropic Receptor Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Glucose Dependent Insulinotropic Receptor Market Forecast

      • 11.1 Global Glucose Dependent Insulinotropic Receptor Production, Revenue Forecast
        • 11.1.1 Global Glucose Dependent Insulinotropic Receptor Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Glucose Dependent Insulinotropic Receptor Price and Trend Forecast (2019-2025)
      • 11.2 Global Glucose Dependent Insulinotropic Receptor Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Glucose Dependent Insulinotropic Receptor Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Glucose Dependent Insulinotropic Receptor Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Glucose Dependent Insulinotropic Receptor Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Glucose Dependent Insulinotropic Receptor Production, Revenue Forecast (2019-2025)
      • 11.3 Global Glucose Dependent Insulinotropic Receptor Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Glucose Dependent Insulinotropic Receptor Consumption Forecast (2019-2025)
        • 11.3.2 Europe Glucose Dependent Insulinotropic Receptor Consumption Forecast (2019-2025)
        • 11.3.3 China Glucose Dependent Insulinotropic Receptor Consumption Forecast (2019-2025)
        • 11.3.4 Japan Glucose Dependent Insulinotropic Receptor Consumption Forecast (2019-2025)
      • 11.4 Global Glucose Dependent Insulinotropic Receptor Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Glucose Dependent Insulinotropic Receptor Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Glucose Dependent Insulinotropic Receptor market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Glucose Dependent Insulinotropic Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glucose Dependent Insulinotropic Receptor market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Amgen Inc
        Arena Pharmaceuticals Inc
        CymaBay Therapeutics Inc
        Dong-A Socio Holdings Co Ltd
        F. Hoffmann-La Roche Ltd
        GlaxoSmithKline Plc
        Hyundai Pharmaceutical Co Ltd
        Kowa Co Ltd
        Merck & Co Inc
        Novartis AG
        Taisho Pharmaceutical Holdings Co Ltd
        Takeda Pharmaceutical Co Ltd
        Yuhan Corp

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        DA-1241
        GSK-2041706
        HD-0471042
        HD-0471953
        HOB-047
        MBX-2982
        Others

        Segment by Application
        Type 2 Diabetes
        Obesity
        Chronic Obstructive Pulmonary Disease (COPD)
        Dyslipidemia
        Others

        Buy now